Don't Miss Out

Subscribe to OCA's News & Alerts.

New Approved Cancer Drugs failing Miserably

According to the National Cancer Institute, in 2012 there were 14 million new cases of cancer diagnosed and 8.2 million cancer deaths worldwide.1 They anticipate the number of newly diagnosed cases will rise to over 20 million each year within the next two decades.

These statistical trends are used to measure success of efforts to prevent or treat cancers. Mainstream medicine relies on pharmaceutical companies to develop toxins that may kill cancer cells and extend the life of those suffering from the disease.

Unfortunately, cancer cells develop in unique and highly variable processes, creating cell overgrowths that do not respond to just one or two types of medication.

Pressured by patient advocates who want earlier access to novel medications, the U.S. Food and Drug Administration (FDA) began approving cancer drugs without requisite proof they either extend the life of the patient or kill cancer cells.2

Meanwhile, emerging evidence indicates diets high in healthy fats, low in net carbs and moderate in protein are ideal to reduce insulin levels, balance leptin and ghrelin hormones, reduce obesity and even help prevent and treat cancers, as it normalizes the underlying metabolic dysfunction.

In other words, this type of nutritional plan improves your overall health, increases your energy level and improves weight loss efforts with a greater proportion of the fat removed from the abdominal cavity, also called visceral fat.3,4

Changing your diet is often financially neutral, while cancer drugs may cost upwards of $171,000 each year for treatment.5

Order Ronnie's New Book: The Truth About COVID-19

Get Local

Find News and Action for your state:
$5 Off Your Next Order at Mercola.com and 20% Goes to Organic Consumers Association.